[Business Models] The End of Biotech?

I recently individually interviewed 10 biotech CEOs and 10 biotech venture capitalists as part of the data collection portion of an executive coaching engagement. It wasn’t the subject of the interview – which was to collect feedback data regarding my coaching client – but everyone to a person brought up the subject of venture capital and biotech.

Everyone talked about the model of investment and development that’s been in existence since Genentech (1976) and Amgen (1980) were founded.… Read the rest

[Career Planning: Mergers & Acquisitions] What Do You Do When the Rumors Start?

Nothing’s guaranteed except change, and in business (as well as more than just a few non-profits) that means a churn of possible mergers, consolidations, and acquisitions. Across the country biotech companies, financial services firms like asset managers, hedge funds, venture capital and private equity firms, and any number of companies in other sectors are all scrambling – some to stay alive, others to grow by acquisition.Read the rest